Prescribing decisions affected by student interaction with marketers

Article

Medical trainees who spend more time with pharmaceutical marketing representatives are less likely to make evidence-based choices when prescribing, according to a study recently published in JAMA Internal Medicine.

Medical trainees who spend more time with pharmaceutical marketing representatives are less likely to make evidence-based choices when prescribing, according to a study recently published in JAMA Internal Medicine.

Researchers surveyed a randomly selected, nationally representative sample of first- and fourth-year medical students, as well as third-year residents.

Study: 90 percent of health-related Wikipedia articles contain errors

“All trainees were asked how often they used different educational resources to learn about prescription drugs. Among fourth-year students and residents, we posed a series of multiple choice knowledge questions asking about the appropriate initial therapy for clinical scenarios involving patients with diabetes, hyperlipidemia, hypertension, and difficulty sleeping,” the study’s authors say.

Participants were also asked about frequency in the past six months of interactions with the pharmaceutical industry, their expected frequency of interactions in their careers, and their attitudes about such interactions. Researchers used the survey answers to build an industry relations index assessing each trainee’s level of acceptance of pharmaceutical promotion.

The study found that 48 percent to 90 percent of fourth-year students and residents accurately identified evidence-based prescribing choices. According to researchers, a 10-point higher industry relations index was associated with 15 percent lower odds of selecting an evidence-based prescribing choice. The study also found there was a significant association between the industry relations index and greater odds of choosing to prescribe brand-name drugs.

The study also found that the 1601 students and 735 residents who participated reported common use of unfiltered sources of drug information such as Google (74.2 percent to 88.9 percent) and Wikipedia (45.2 percent to 84.5 percent).

Recent Videos
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
The California Optometric Association and the Los Angeles County Optometric Society have compiled resources for optometrists to get involved in continuing relief efforts.
Dr. Stephanie Woo discusses the upcoming CRU Eye Symposium
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
© 2025 MJH Life Sciences

All rights reserved.